25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JSPRW (Jasper Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Jasper Therapeutics Inc together

I guess you are interested in Jasper Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Jasper Therapeutics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Jasper Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Jasper Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Jasper Therapeutics Inc

I send you an email if I find something interesting about Jasper Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Jasper Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Jasper Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.53
Expected worth in 1 year
$-3.63
How sure are you?
31.8%

+ What do you gain per year?

Total Gains per Share
$-5.16
Return On Investment
-3,739.8%

For what price can you sell your share?

Current Price per Share
$0.14
Expected price per share
$0.078 - $0.1775
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jasper Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.14
Intrinsic Value Per Share
$-41.43 - $-47.06
Total Value Per Share
$-39.90 - $-45.53

2.2. Growth of Jasper Therapeutics Inc (5 min.)




Is Jasper Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$23.5m$96.5m-$43.7m-82.9%

How much money is Jasper Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$22.7m-$15.6m-$7.1m-31.3%
Net Profit Margin-517.9%-202.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Jasper Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#470 / 843

Most Revenue
#540 / 843

Most Profit
#642 / 843

Most Efficient
#590 / 843
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jasper Therapeutics Inc?

Welcome investor! Jasper Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Jasper Therapeutics Inc.

First you should know what it really means to hold a share of Jasper Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Jasper Therapeutics Inc is $0.138. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jasper Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jasper Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.53. Based on the TTM, the Book Value Change Per Share is $-1.29 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jasper Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.74-1,262.8%-1.52-1,099.0%-1.28-924.4%-1.76-1,274.6%-1.38-999.3%-1.20-871.4%
Usd Book Value Change Per Share-1.28-927.2%-1.29-935.0%-0.85-615.5%-1.22-882.6%-8.26-5,985.9%0.0750.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.28-927.2%-1.29-935.0%-0.85-615.5%-1.22-882.6%-8.26-5,985.9%0.0750.5%
Usd Price Per Share0.12-0.13-0.13-0.12-0.47-0.50-
Price to Earnings Ratio-0.02--0.02--0.03--0.02--0.83--0.77-
Price-to-Total Gains Ratio-0.10--0.14--0.02--0.05--0.04--0.04-
Price to Book Ratio0.08-0.04-0.02-0.02--0.02--0.02-
Price-to-Total Gains Ratio-0.10--0.14--0.02--0.05--0.04--0.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.138
Number of shares7246
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.29-8.26
Usd Total Gains Per Share-1.29-8.26
Gains per Quarter (7246 shares)-9,349.10-59,855.49
Gains per Year (7246 shares)-37,396.39-239,421.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-37396-374060-239422-239432
20-74793-748020-478844-478854
30-112189-1121980-718266-718276
40-149586-1495940-957688-957698
50-186982-1869900-1197110-1197120
60-224378-2243860-1436532-1436542
70-261775-2617820-1675954-1675964
80-299171-2991780-1915376-1915386
90-336567-3365740-2154797-2154808
100-373964-3739700-2394219-2394230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%2.020.00.09.1%2.020.00.09.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%7.015.00.031.8%7.015.00.031.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.022.00.0%0.00.022.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%7.015.00.031.8%7.015.00.031.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Jasper Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.280-1.290+1%-0.849-34%-1.218-5%-8.260+546%0.070-1937%
Book Value Per Share--1.5333.538-57%7.717-80%7.678-80%8.835-83%199.838-99%
Current Ratio--2.0964.748-56%10.078-79%8.523-75%8.115-74%18.672-89%
Debt To Asset Ratio--0.4940.287+72%0.135+265%0.196+152%0.299+65%0.275+79%
Debt To Equity Ratio--0.9770.456+114%0.158+520%0.273+258%0.374+161%0.382+156%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--18460211.85451568087.285-64%90957092.500-80%73193393.278-75%58121031.429-68%53600462.245-66%
Eps---1.743-1.517-13%-1.276-27%-1.759+1%-1.379-21%-1.203-31%
Ev To Ebitda Ratio---0.170-0.619+263%-1.385+712%-1.118+556%-3.615+2021%-3.080+1707%
Free Cash Flow Per Share---2.474-1.601-35%-1.144-54%-1.629-34%-1.582-36%-1.442-42%
Free Cash Flow To Equity Per Share---2.072-1.495-28%-0.259-88%-0.340-84%0.131-1684%0.117-1874%
Gross Profit Margin--1.0001.0030%1.010-1%1.0040%1.0020%1.0020%
Intrinsic Value_10Y_max---47.059----------
Intrinsic Value_10Y_min---41.434----------
Intrinsic Value_1Y_max---6.263----------
Intrinsic Value_1Y_min---6.153----------
Intrinsic Value_3Y_max---17.638----------
Intrinsic Value_3Y_min---16.863----------
Intrinsic Value_5Y_max---27.592----------
Intrinsic Value_5Y_min---25.712----------
Market Cap--1915211.8541994565.463-4%1714092.500+12%1538193.838+25%7180839.208-73%6555421.916-71%
Net Profit Margin----5.1790%-2.0200%-2.4000%-1.3850%-1.2590%
Operating Margin----4.6440%-2.1590%-2.2680%-1.2750%-1.1590%
Operating Ratio---5.509-100%2.169-100%2.560-100%1.451-100%1.319-100%
Pb Ratio0.090+9%0.0810.042+95%0.017+377%0.023+261%-0.024+129%-0.021+126%
Pe Ratio-0.020-10%-0.018-0.022+25%-0.029+63%-0.022+25%-0.828+4522%-0.772+4208%
Price Per Share0.138+9%0.1250.134-7%0.128-2%0.123+1%0.470-73%0.502-75%
Price To Free Cash Flow Ratio-0.014-10%-0.013-0.025+100%-0.032+151%-0.026+102%-18.847+149246%-19.176+151855%
Price To Total Gains Ratio-0.108-10%-0.098-0.144+48%-0.017-83%-0.047-52%-0.042-57%-0.038-61%
Quick Ratio--1.9274.507-57%9.935-81%8.297-77%7.795-75%40.508-95%
Return On Assets---0.575-0.359-38%-0.143-75%-0.226-61%-0.187-68%-0.174-70%
Return On Equity---1.137-0.564-50%-0.166-85%-0.316-72%-0.420-63%-0.470-59%
Total Gains Per Share---1.280-1.290+1%-0.849-34%-1.218-5%-8.260+546%0.070-1937%
Usd Book Value--23501000.00052774750.000-55%96528250.000-76%76347416.667-69%71491631.400-67%73897907.727-68%
Usd Book Value Change Per Share---1.280-1.290+1%-0.849-34%-1.218-5%-8.260+546%0.070-1937%
Usd Book Value Per Share--1.5333.538-57%7.717-80%7.678-80%8.835-83%199.838-99%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--18460211.85451568087.285-64%90957092.500-80%73193393.278-75%58121031.429-68%53600462.245-66%
Usd Eps---1.743-1.517-13%-1.276-27%-1.759+1%-1.379-21%-1.203-31%
Usd Free Cash Flow---37941124.000-24084781.000-37%-14072000.000-63%-16572010.333-56%-13210602.550-65%-12009863.545-68%
Usd Free Cash Flow Per Share---2.474-1.601-35%-1.144-54%-1.629-34%-1.582-36%-1.442-42%
Usd Free Cash Flow To Equity Per Share---2.072-1.495-28%-0.259-88%-0.340-84%0.131-1684%0.117-1874%
Usd Market Cap--1915211.8541994565.463-4%1714092.500+12%1538193.838+25%7180839.208-73%6555421.916-71%
Usd Price Per Share0.138+9%0.1250.134-7%0.128-2%0.123+1%0.470-73%0.502-75%
Usd Profit---26723000.000-22730500.000-15%-15609000.000-42%-17397666.667-35%-13641600.000-49%-12894954.545-52%
Usd Revenue---293500.000-100%513000.000-100%268833.333-100%296548.550-100%269589.591-100%
Usd Total Gains Per Share---1.280-1.290+1%-0.849-34%-1.218-5%-8.260+546%0.070-1937%
 EOD+3 -3MRQTTM+8 -27YOY+5 -303Y+7 -285Y+7 -2810Y+3 -32

3.3 Fundamental Score

Let's check the fundamental score of Jasper Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.020
Price to Book Ratio (EOD)Between0-10.090
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.927
Current Ratio (MRQ)Greater than12.096
Debt to Asset Ratio (MRQ)Less than10.494
Debt to Equity Ratio (MRQ)Less than10.977
Return on Equity (MRQ)Greater than0.15-1.137
Return on Assets (MRQ)Greater than0.05-0.575
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Jasper Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.077
Ma 20Greater thanMa 500.107
Ma 50Greater thanMa 1000.093
Ma 100Greater thanMa 2000.101
OpenGreater thanClose0.138
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Jasper Therapeutics Inc

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.

Fundamental data was last updated by Penke on 2025-10-31 21:31:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Jasper Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jasper Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-517.9%+517.9%
TTM-517.9%YOY-202.0%-315.9%
TTM-517.9%5Y-138.5%-379.4%
5Y-138.5%10Y-125.9%-12.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--78.6%+78.6%
TTM-517.9%-163.3%-354.6%
YOY-202.0%-187.9%-14.1%
3Y-240.0%-262.6%+22.6%
5Y-138.5%-338.6%+200.1%
10Y-125.9%-470.4%+344.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Jasper Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • -57.5% Return on Assets means thatΒ Jasper Therapeutics Inc generatedΒ $-0.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jasper Therapeutics Inc:

  • The MRQ is -57.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -35.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-57.5%TTM-35.9%-21.6%
TTM-35.9%YOY-14.3%-21.6%
TTM-35.9%5Y-18.7%-17.2%
5Y-18.7%10Y-17.4%-1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-57.5%-11.8%-45.7%
TTM-35.9%-11.5%-24.4%
YOY-14.3%-11.2%-3.1%
3Y-22.6%-12.0%-10.6%
5Y-18.7%-11.6%-7.1%
10Y-17.4%-13.7%-3.7%
4.3.1.3. Return on Equity

Shows how efficient Jasper Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • -113.7% Return on Equity means Jasper Therapeutics Inc generated $-1.14Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jasper Therapeutics Inc:

  • The MRQ is -113.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -56.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-113.7%TTM-56.4%-57.3%
TTM-56.4%YOY-16.6%-39.8%
TTM-56.4%5Y-42.0%-14.5%
5Y-42.0%10Y-47.0%+5.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-113.7%-13.8%-99.9%
TTM-56.4%-14.7%-41.7%
YOY-16.6%-15.1%-1.5%
3Y-31.6%-16.7%-14.9%
5Y-42.0%-16.9%-25.1%
10Y-47.0%-19.5%-27.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Jasper Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Jasper Therapeutics Inc is operatingΒ .

  • Measures how much profit Jasper Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jasper Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-464.4%+464.4%
TTM-464.4%YOY-215.9%-248.4%
TTM-464.4%5Y-127.5%-336.8%
5Y-127.5%10Y-115.9%-11.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--164.5%+164.5%
TTM-464.4%-266.6%-197.8%
YOY-215.9%-248.7%+32.8%
3Y-226.8%-248.8%+22.0%
5Y-127.5%-331.9%+204.4%
10Y-115.9%-501.5%+385.6%
4.3.2.2. Operating Ratio

Measures how efficient Jasper Therapeutics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Jasper Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.509-5.509
TTM5.509YOY2.169+3.340
TTM5.5095Y1.451+4.059
5Y1.45110Y1.319+0.132
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.898-1.898
TTM5.5092.722+2.787
YOY2.1692.848-0.679
3Y2.5603.562-1.002
5Y1.4514.571-3.120
10Y1.3196.306-4.987
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Jasper Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jasper Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.10Β means the company has $2.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Jasper Therapeutics Inc:

  • The MRQ is 2.096. The company is able to pay all its short-term debts. +1
  • The TTM is 4.748. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.096TTM4.748-2.652
TTM4.748YOY10.078-5.330
TTM4.7485Y8.115-3.367
5Y8.11510Y18.672-10.557
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0963.272-1.176
TTM4.7483.570+1.178
YOY10.0784.010+6.068
3Y8.5234.376+4.147
5Y8.1155.701+2.414
10Y18.6726.070+12.602
4.4.3.2. Quick Ratio

Measures if Jasper Therapeutics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.93Β means the company can pay off $1.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jasper Therapeutics Inc:

  • The MRQ is 1.927. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.507. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.927TTM4.507-2.580
TTM4.507YOY9.935-5.427
TTM4.5075Y7.795-3.288
5Y7.79510Y40.508-32.713
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9272.909-0.982
TTM4.5073.149+1.358
YOY9.9353.831+6.104
3Y8.2974.393+3.904
5Y7.7955.686+2.109
10Y40.5086.469+34.039
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Jasper Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Jasper Therapeutics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Jasper Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49Β means that Jasper Therapeutics Inc assets areΒ financed with 49.4% credit (debt) and the remaining percentage (100% - 49.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Jasper Therapeutics Inc:

  • The MRQ is 0.494. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.494TTM0.287+0.207
TTM0.287YOY0.135+0.151
TTM0.2875Y0.299-0.012
5Y0.29910Y0.275+0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4940.349+0.145
TTM0.2870.364-0.077
YOY0.1350.335-0.200
3Y0.1960.353-0.157
5Y0.2990.348-0.049
10Y0.2750.379-0.104
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Jasper Therapeutics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 97.7% means that company has $0.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jasper Therapeutics Inc:

  • The MRQ is 0.977. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.456. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.977TTM0.456+0.521
TTM0.456YOY0.158+0.298
TTM0.4565Y0.374+0.082
5Y0.37410Y0.382-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9770.410+0.567
TTM0.4560.448+0.008
YOY0.1580.431-0.273
3Y0.2730.473-0.200
5Y0.3740.474-0.100
10Y0.3820.523-0.141
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Jasper Therapeutics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Jasper Therapeutics Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.02 means the investor is paying $-0.02Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jasper Therapeutics Inc:

  • The EOD is -0.020. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.018. Based on the earnings, the company is expensive. -2
  • The TTM is -0.022. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.020MRQ-0.018-0.002
MRQ-0.018TTM-0.022+0.004
TTM-0.022YOY-0.029+0.007
TTM-0.0225Y-0.828+0.806
5Y-0.82810Y-0.772-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.020-2.703+2.683
MRQ-0.018-2.294+2.276
TTM-0.022-2.664+2.642
YOY-0.029-3.568+3.539
3Y-0.022-3.737+3.715
5Y-0.828-5.932+5.104
10Y-0.772-6.842+6.070
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jasper Therapeutics Inc:

  • The EOD is -0.014. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.013. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.025. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.014MRQ-0.013-0.001
MRQ-0.013TTM-0.025+0.013
TTM-0.025YOY-0.032+0.006
TTM-0.0255Y-18.847+18.822
5Y-18.84710Y-19.176+0.329
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.014-3.420+3.406
MRQ-0.013-2.907+2.894
TTM-0.025-3.843+3.818
YOY-0.032-4.299+4.267
3Y-0.026-5.307+5.281
5Y-18.847-8.253-10.594
10Y-19.176-9.824-9.352
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Jasper Therapeutics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.08 means the investor is paying $0.08Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Jasper Therapeutics Inc:

  • The EOD is 0.090. Based on the equity, the company is cheap. +2
  • The MRQ is 0.081. Based on the equity, the company is cheap. +2
  • The TTM is 0.042. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.090MRQ0.081+0.009
MRQ0.081TTM0.042+0.040
TTM0.042YOY0.017+0.025
TTM0.0425Y-0.024+0.065
5Y-0.02410Y-0.021-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0902.316-2.226
MRQ0.0812.061-1.980
TTM0.0422.230-2.188
YOY0.0172.489-2.472
3Y0.0232.654-2.631
5Y-0.0243.761-3.785
10Y-0.0214.406-4.427
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Jasper Therapeutics Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets46,466
Total Liabilities22,965
Total Stockholder Equity23,501
 As reported
Total Liabilities 22,965
Total Stockholder Equity+ 23,501
Total Assets = 46,466

Assets

Total Assets46,466
Total Current Assets42,966
Long-term Assets3,500
Total Current Assets
Cash And Cash Equivalents 39,510
Other Current Assets 3,456
Total Current Assets  (as reported)42,966
Total Current Assets  (calculated)42,966
+/-0
Long-term Assets
Property Plant Equipment 2,891
Long-term Assets Other 192
Long-term Assets  (as reported)3,500
Long-term Assets  (calculated)3,083
+/- 417

Liabilities & Shareholders' Equity

Total Current Liabilities20,500
Long-term Liabilities2,465
Total Stockholder Equity23,501
Total Current Liabilities
Short-term Debt 1,954
Accounts payable 8,034
Other Current Liabilities 10,512
Total Current Liabilities  (as reported)20,500
Total Current Liabilities  (calculated)20,500
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt201
Long-term Liabilities Other 2,264
Long-term Liabilities  (as reported)2,465
Long-term Liabilities  (calculated)2,465
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -288,833
Other Stockholders Equity 312,332
Total Stockholder Equity (as reported)23,501
Total Stockholder Equity (calculated)23,501
+/-0
Other
Capital Stock2
Cash and Short Term Investments 39,510
Common Stock Shares Outstanding 15,334
Liabilities and Stockholders Equity 46,466
Net Debt -37,355
Net Invested Capital 23,501
Net Working Capital 22,466
Property Plant and Equipment Gross 6,707
Short Long Term Debt Total 2,155



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
100,155
101,694
101,597
101,318
23,357
100,960
100,549
107,213
93,654
80,548
70,366
59,110
48,361
138,757
124,170
110,405
94,892
125,963
113,929
99,413
79,899
57,597
46,466
46,46657,59779,89999,413113,929125,96394,892110,405124,170138,75748,36159,11070,36680,54893,654107,213100,549100,96023,357101,318101,597101,694100,155
   > Total Current Assets 
100,155
27,163
1,181
964
20,685
757
423
102,407
87,831
73,799
63,286
52,411
41,731
132,508
118,567
105,218
88,938
120,308
108,680
94,806
75,811
53,174
42,966
42,96653,17475,81194,806108,680120,30888,938105,218118,567132,50841,73152,41163,28673,79987,831102,40742375720,6859641,18127,163100,155
       Cash And Cash Equivalents 
1,213
-27,163
914
758
19,838
591
310
100,905
84,701
70,400
60,814
50,950
38,250
129,400
115,812
103,867
86,887
118,475
106,819
92,502
71,637
48,799
39,510
39,51048,79971,63792,502106,819118,47586,887103,867115,812129,40038,25050,95060,81470,40084,701100,90531059119,838758914-27,1631,213
       Short-term Investments 
100,155
54,326
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000054,326100,155
       Net Receivables 
0
0
0
0
600
0
0
298
698
563
443
384
663
250
330
268
250
250
250
250
0
0
0
000250250250250268330250663384443563698298006000000
       Inventory 
0
0
0
0
0
0
0
1,194
-698
2,809
2,002
-384
0
1,867
1,772
672
0
0
0
0
0
0
0
00000006721,7721,8670-3842,0022,809-6981,1940000000
   > Long-term Assets 
100,155
-27,163
100,416
100,355
2,672
100,204
100,126
4,806
5,823
6,749
7,080
6,699
6,630
6,249
5,603
5,187
6,442
5,655
5,249
4,607
4,088
4,423
3,500
3,5004,4234,0884,6075,2495,6556,4425,1875,6036,2496,6306,6997,0806,7495,8234,806100,126100,2042,672100,355100,416-27,163100,155
       Property Plant Equipment 
0
0
0
0
2,029
0
4,047
4,461
4,833
5,721
6,086
5,739
5,454
5,107
4,741
4,359
4,194
3,815
3,669
3,177
2,851
3,474
2,891
2,8913,4742,8513,1773,6693,8154,1944,3594,7415,1075,4545,7396,0865,7214,8334,4614,04702,0290000
       Long Term Investments 
100,155
100,403
100,416
100,355
0
100,204
100,126
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000100,126100,2040100,355100,416100,403100,155
       Other Assets 
0
101,694
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000101,6940
> Total Liabilities 
3,611
3,611
3,758
3,680
58,487
11,101
14,259
28,611
24,136
12,443
11,585
11,545
12,372
13,559
13,965
16,272
16,452
12,733
13,619
15,733
18,225
15,353
22,965
22,96515,35318,22515,73313,61912,73316,45216,27213,96513,55912,37211,54511,58512,44324,13628,61114,25911,10158,4873,6803,7583,6113,611
   > Total Current Liabilities 
111
111
258
180
4,012
181
329
9,159
8,020
5,969
6,622
7,421
7,065
7,892
8,972
11,906
12,374
8,916
10,068
12,459
15,237
12,334
20,500
20,50012,33415,23712,45910,0688,91612,37411,9068,9727,8927,0657,4216,6225,9698,0209,1593291814,012180258111111
       Short-term Debt 
0
0
0
0
0
0
424
980
505
1,042
1,568
1,680
865
1,782
1,834
1,890
1,944
2,000
1,029
1,059
1,089
1,835
1,954
1,9541,8351,0891,0591,0292,0001,9441,8901,8341,7828651,6801,5681,042505980424000000
       Accounts payable 
111
171
258
180
1,417
181
4,612
2,247
3,919
1,466
2,997
3,117
1,768
3,846
1,581
3,256
4,149
2,391
2,964
3,086
4,027
2,995
8,034
8,0342,9954,0273,0862,9642,3914,1493,2561,5813,8461,7683,1172,9971,4663,9192,2474,6121811,417180258171111
       Other Current Liabilities 
0
95
185
172
2,590
181
-4,717
5,932
3,596
3,356
2,057
2,624
4,432
2,264
5,557
6,760
6,281
4,525
6,075
8,314
10,121
7,504
10,512
10,5127,50410,1218,3146,0754,5256,2816,7605,5572,2644,4322,6242,0573,3563,5965,932-4,7171812,590172185950
   > Long-term Liabilities 
3,500
3,500
3,500
3,500
54,475
10,920
13,930
19,452
16,116
6,474
4,963
4,124
5,307
5,667
4,993
4,366
2,302
3,817
3,551
3,274
2,988
3,019
2,465
2,4653,0192,9883,2743,5513,8172,3024,3664,9935,6675,3074,1244,9636,47416,11619,45213,93010,92054,4753,5003,5003,5003,500
       Long term Debt Total 
0
0
0
0
0
7,420
10,430
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,4307,42000000
       Warrants
93,082
93,121
92,839
92,638
0
84,860
81,290
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000081,29084,860092,63892,83993,12193,082
> Total Stockholder Equity
5,000
21,102
5,000
5,000
-35,130
5,000
86,290
78,602
69,518
68,105
58,781
47,565
35,989
125,198
110,205
94,133
78,440
113,230
100,310
83,680
61,674
42,244
23,501
23,50142,24461,67483,680100,310113,23078,44094,133110,205125,19835,98947,56558,78168,10569,51878,60286,2905,000-35,1305,0005,00021,1025,000
   Common Stock
0
93,083
92,839
92,638
1
84,860
81,291
4
4
4
4
4
4
11
11
11
1
2
2
2
2
2
2
222222111111144444481,29184,860192,63892,83993,0830
   Retained Earnings Total Equity
2
41
-241
-442
0
-1,579
-5,149
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000-5,149-1,5790-442-241412
   Accumulated Other Comprehensive Income 000000000000000-107,21300-43,84000-4,7340
   Capital Surplus 
4,998
4,959
5,241
5,442
0
6,579
10,148
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,1486,57905,4425,2414,9594,998
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
-88,085
-87,598
-87,196
41,812
-78,281
-56,101
244,204
136,964
137,758
138,838
139,485
141,124
244,582
245,669
247,141
248,039
296,556
298,219
300,226
302,541
304,352
312,332
312,332304,352302,541300,226298,219296,556248,039247,141245,669244,582141,124139,485138,838137,758136,964244,204-56,101-78,28141,812-87,196-87,598-88,0850



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,373
Gross Profit-1,373-1,373
 
Operating Income (+$)
Gross Profit-1,373
Operating Expense-76,239
Operating Income-77,731-77,612
 
Operating Expense (+$)
Research Development55,821
Selling General Administrative20,418
Selling And Marketing Expenses0
Operating Expense76,23976,239
 
Net Interest Income (+$)
Interest Income5,058
Interest Expense-0
Other Finance Cost-0
Net Interest Income5,058
 
Pretax Income (+$)
Operating Income-77,731
Net Interest Income5,058
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-72,761-82,701
EBIT - interestExpense = -72,761
-72,761
-71,269
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-72,761-72,761
Earnings Before Interest and Taxes (EBITDA)-71,388
 
After tax Income (+$)
Income Before Tax-72,761
Tax Provision-0
Net Income From Continuing Ops-71,269-72,761
Net Income-71,269
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses76,239
Total Other Income/Expenses Net4,970-5,058
 

Technical Analysis of Jasper Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jasper Therapeutics Inc. The general trend of Jasper Therapeutics Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jasper Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Jasper Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jasper Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.14 < 0.1475 < 0.1775.

The bearish price targets are: 0.1199 > 0.078 > 0.078.

Know someone who trades $JSPRW? Share this with them.πŸ‘‡

Jasper Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jasper Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jasper Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jasper Therapeutics Inc. The current macd is 0.00819176.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jasper Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jasper Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jasper Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jasper Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartJasper Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jasper Therapeutics Inc. The current adx is 15.05.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jasper Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jasper Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jasper Therapeutics Inc. The current sar is 0.08.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jasper Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jasper Therapeutics Inc. The current rsi is 64.08. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Jasper Therapeutics Inc Daily Relative Strength Index (RSI) ChartJasper Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jasper Therapeutics Inc. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jasper Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jasper Therapeutics Inc Daily Stochastic Oscillator ChartJasper Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jasper Therapeutics Inc. The current cci is 234.99.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Jasper Therapeutics Inc Daily Commodity Channel Index (CCI) ChartJasper Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jasper Therapeutics Inc. The current cmo is 37.31.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jasper Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartJasper Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jasper Therapeutics Inc. The current willr is -3.22580645.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Jasper Therapeutics Inc Daily Williams %R ChartJasper Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Jasper Therapeutics Inc.

Jasper Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jasper Therapeutics Inc. The current atr is 0.02609955.

Jasper Therapeutics Inc Daily Average True Range (ATR) ChartJasper Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jasper Therapeutics Inc. The current obv is -133,639.

Jasper Therapeutics Inc Daily On-Balance Volume (OBV) ChartJasper Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jasper Therapeutics Inc. The current mfi is 68.16.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jasper Therapeutics Inc Daily Money Flow Index (MFI) ChartJasper Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jasper Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-11-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Jasper Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jasper Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.077
Ma 20Greater thanMa 500.107
Ma 50Greater thanMa 1000.093
Ma 100Greater thanMa 2000.101
OpenGreater thanClose0.138
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jasper Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Jasper Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jasper Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jasper Therapeutics Inc

I send you an email if I find something interesting about Jasper Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Jasper Therapeutics Inc.

Receive notifications about Jasper Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.